Webinars overview

As part of its investment in e-learning for Fellows and members, the College is running a series of monthly webinars alternating between oncology and radiology themes. The webinars will be facilitated by leading experts from each specialty and cover various hot topics and essential training issues. The duration of each will be approximately 60 minutes and RCR members will have the opportunity to interact live with speakers and fellow participants. CPD credits will be awarded and for those unable to participate, recordings will be made available via the Previous webinars tab (login is required).

Upcoming webinars

19 September 2018 - PRIMETIME: Post-operative avoidance of radiotherapy: biomarker selection of women at very low risk of local recurrence

Led by: Dr Charlotte Coles and Dr Indrani Bhattacharya 

PRIMETIME is a prospective, biomarker-directed case-cohort multi-centre study aiming to obtain evidence supporting the safe avoidance of radiotherapy. It is sponsored by the Institute of Cancer Research and funded by Cancer Research UK. The biomarker IHC4+C is used to identify patients at such low risk of local relapse that the potential benefits of radiotherapy are unlikely to outweigh the known risks. This UK study started on 18th of May 2017 and 26 centres have opened, with a plan to open a further 15 centres by the end of 2018. Recruitment is likely to continue until  2020-2021.
The PRIMETIME Information Giving Study is an embedded sub-study. It is investigating whether the addition of a decision aid video to standard written patient information can reduce uncertainty (decisional conflict) for patient’s considering participation within PRIMETIME.

27 September 2018 - Aortic Dissection

Led by: Professor Mark Callaway

Aortic dissection is a medical emergency that if undiagnosed can be fatal.

The Patient Association, Aortic Dissection Awareness (UK & Ireland), says that a diagnosis of Aortic dissection is considered in less than half of patients who arrive at A&E with the condition and that one-third of patients with Aortic Dissection are actively treated in the Emergency Department for a different, incorrect diagnosis. Despite the advances of modern medicine the rate of aortic dissection has  increased from 2.49 per 100 000 to 2.78 per 100 000 inhabitants between 1990 and 2010, with higher rates for men. The only way to definitively diagnose Aortic dissection is by a CT scan.

This webinar brings together experts in AD and Radiology to discuss this important disease and how early CT imaging has a major role in the management of this condition.

31 October 2018 A gene signature for selecting benefit from Hypoxia Modification of radiotherapy for high-risk bladder cancer patients

CO Journal club webinar

Led by: Dr Yee Pei Song and Dr Ananya Choudhury

Curative treatment options for muscle-invasive bladder cancer include either radical cystectomy or tri-modality bladder preserving treatment (TMT). The addition of radiosensitizers, in the form of chemotherapy agents or hypoxia-modifying agents, to radical radiotherapy has been shown to improve outcomes. There are various radiosensitizing regimens in use in the UK and choice is largely centre dependent. As we move towards the provision of personalised treatment plans, it is vital to consider scientific methods of biologically stratifying patients to the most appropriate treatment option. This article discusses the development of a gene signature that predicts benefit from hypoxia-modifying agents.